Join to View Full Profile
702 Barnhill DrIndianapolis, IN 46202
Phone+1 317-274-8103
Fax+1 317-274-1111
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gavin Roberts, MD is a board certified ophthalmologist in Indianapolis, Indiana. He is currently licensed to practice medicine in Indiana, Texas, and Wisconsin.
Education & Training
Medical College of Wisconsin Affiliated HospitalsResidency, Ophthalmology, 1992 - 1995
Ascension St Vincent Hospital IndianapolisInternship, Transitional Year, 1991 - 1992
Indiana University School of MedicineClass of 1991
Certifications & Licensure
IN State Medical License 1995 - 2025
TX State Medical License 2002 - 2004
WI State Medical License 1992 - 1995
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Immediate Postoperative Alignment Measurements as a Predictor of Alignment Stability in Fixed Suture Strabismus Surgery.Charline S. Boente, Griffin J. Jardine, Tina G. Damarjian, Derek T. Sprunger, Gavin J. Roberts
Journal of Pediatric Ophthalmology and Strabismus. 2018-05-01 - 33 citationsA pilot randomized clinical trial of intermittent occlusion therapy liquid crystal glasses versus traditional patching for treatment of moderate unilateral amblyopia.Jingyun Wang, Daniel E. Neely, Jay Galli, Joshua Schliesser, April Graves
Journal of AAPOS. 2016-08-01 - 19 citationsMacular structural characteristics in children with Down syndromeScott O’Brien, Jingyun Wang, Heather A. Smith, Dana Donaldson, Kathryn M. Haider
Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2015-07-02
Press Mentions
Are Long-Term Pricing Controls Here to Stay? Three Reasons the Optimists Might Be RightFebruary 1st, 2021
